ARWR Receives EU Approval
Arrowhead Pharmaceuticals receives EU marketing authorization for REDEMPLO to reduce triglycerides in adults with Familial Chylomicronemia Syndrome
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.